ARTICLE | Clinical News
OmniSeq Target regulatory update
July 28, 2014 7:00 AM UTC
Roswell Park said the New York State Department of Health approved the company’s OmniSeq Target test as a genomic test for cancer patients. The molecular diagnostic test uses next-generation sequencin...